Lv7
3870 积分 2023-12-05 加入
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial
1个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus
3个月前
已完结
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
5个月前
已完结
Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
5个月前
已完结
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus
5个月前
已完结
Daratumumab monotherapy reverses the immune and pro-fibrotic profiles in refractory lupus nephritis patients: a pilot case study
5个月前
已完结
BCMA-Targeted T-Cell Engager for Autoimmune Hemolytic Anemia after CD19 CAR T-Cell Therapy
8个月前
已完结
Efficacy and safety of nipocalimab in patients with moderate-to-severe Sjögren's disease (DAHLIAS): a randomised, phase 2, placebo-controlled, double-blind trial
8个月前
已完结
Comparison of Obinutuzumab and Rituximab for Treating Primary Membranous Nephropathy
8个月前
已完结